跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用头孢洛生他唑巴坦钠 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ceftolozane Sulfate and Tazobactam Sodium for Injection
Approved
化学药品
Ceftolozane Sulfate and Tazobactam Sodium for Injection
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
Feb 8, 2025
Approval ID
8h2lTTyehNW
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
8h2lTTyehNW
Approval Number
国药准字HJ20250016
Generic Name
注射用头孢洛生他唑巴坦钠
Generic Name En
Ceftolozane Sulfate and Tazobactam Sodium for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.5g（C₂₃H₃₀N₁₂O₈S₂ 1.0g与C₁₀H₁₂N₄O₅S 0.5g）
Reg Date
2025-02-08
Expired Date
2030-02-07
Company Name
Merck Sharp & Dohme BV
Production Company Name
Steri-Pharma, LLC
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Production Company Detail Path
/organization/steri-pharma-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 8, 2025
Approval ID
8h2lTTyehNW
Type
化学药品
Back to NMPA Approvals
